Actuate Therapeutics ACTU
NASDAQ ACTU
$0.76 +0.07 (+10.28%)
As of: Sep 30, 2026 · 12:43 PM EDT

Actuate Therapeutics, Inc. (ACTU) Payables (2023 - 2026)

Updated

Actuate Therapeutics (ACTU) posted Payables of $1.08 million for Q2 2026, down 66.0% from $3.17 million a year earlier.

Analysis

Actuate Therapeutics, Inc. (ACTU) Payables (2023 - 2026) Analysis & Trends

At the end of FY2025, Actuate Therapeutics' Payables came in at $1.52 million, down 20.7% from FY2024.

  • In prior years, Actuate Therapeutics' Payables was $1.92 million in FY2024 (-43.9%) and $3.42 million in FY2023.
  • The Q2 2026 figure stands as the lowest quarterly Payables in data going back to Q4 2023.
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.08 Mn
Dec 31, 2025 1.52 Mn
Sep 30, 2025 1.25 Mn
Jun 30, 2025 3.17 Mn
Mar 31, 2025 2.64 Mn
Dec 31, 2024 1.92 Mn
Sep 30, 2024 2.33 Mn
Jun 30, 2024 12.79 Mn
Dec 31, 2023 3.42 Mn
API Access

Actuate Therapeutics, Inc. Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=payables&ticker=ACTU&period=max&api_key=YOUR_API_KEY